BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4033621)

  • 21. Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy.
    Alderman MH; Melcher L; Drayer DE; Reidenberg MM
    N Engl J Med; 1983 Nov; 309(20):1213-7. PubMed ID: 6633570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y; Kawada T; Sugino N
    Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in N-acetyl-beta-glucosaminidase (NAG) in prostatitis patients].
    Yasumoto R; Kobayakawa H; Kakinoki K; Iseki T; Umeda M; Kawashima H; Moriya K; Maekawa M
    Hinyokika Kiyo; 1986 Jun; 32(6):841-5. PubMed ID: 3766344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
    Lacour B; Lacroix C; Jungers P; Bailly M
    Ann Biol Clin (Paris); 1984; 42(6):407-11. PubMed ID: 6532266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase.
    Fujita K; Murayama T; Kawamura M; Narita K
    Int J Clin Pharmacol Res; 1987; 7(6):477-80. PubMed ID: 3440638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetyl-beta-D-glucosaminidase is not a predictor, but an indicator of kidney injury in patients with cardiac surgery.
    Hamada Y; Kanda T; Anzai T; Kobayashi I; Morishita Y
    J Med; 1999; 30(5-6):329-36. PubMed ID: 10851566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetyl-beta-glucosaminidase in the localization of the site of urinary tract infections.
    Chan MK
    Singapore Med J; 1990 Apr; 31(2):135-7. PubMed ID: 2371577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 1. Description of NAG activity determination].
    Noto A; Mori S; Nakamura M; Kitakaze T
    Rinsho Byori; 1983 Sep; Spec No 56():65-72. PubMed ID: 6663762
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of enzymuria and proteinuria: Report 2; Relationship between glomerular filtration rate and urinary enzymuria and proteinuria].
    Yasumoto R; Tanaka S; Kawashima H; Kakinoki K; Iseki T; Umeda M; Tanabe S; Nishisaka N; Asakawa M
    Hinyokika Kiyo; 1989 Jul; 35(7):1125-8. PubMed ID: 2478007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influences of percutaneous nephrolithotomy on renal function, an observation using the NAG-index and beta 2-microglobulin as indices].
    Yajima I; Nishimura T; Yoshida K; Tomita M; Hikima N; Kawamura N; Tsuboi N; Honda R; Akimoto M
    Hinyokika Kiyo; 1987 May; 33(5):662-8. PubMed ID: 3310555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial.
    Hynninen MS; Niemi TT; Pöyhiä R; Raininko EI; Salmenperä MT; Lepäntalo MJ; Railo MJ; Tallgren MK
    Anesth Analg; 2006 Jun; 102(6):1638-45. PubMed ID: 16717300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia.
    Jepson RE; Vallance C; Syme HM; Elliott J
    Am J Vet Res; 2010 Feb; 71(2):241-7. PubMed ID: 20113234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estimation of urinary excretion rate of guanidinoacetic acid in essential hypertension].
    Takano Y
    Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1187-96. PubMed ID: 2696798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract]   [Full Text] [Related]  

  • 37. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
    Sano K; Uno E
    Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria.
    Skalova S; Palicka V; Kutilek S
    Nephrology (Carlton); 2005 Apr; 10(2):99-102. PubMed ID: 15877664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
    Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K
    Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
    [No Abstract]   [Full Text] [Related]  

  • 40. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.